Concepedia

Publication | Closed Access

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network

57

Citations

40

References

2017

Year

References

YearCitations

Page 1